Summit Therapeutics Inc.SMMTNASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank100
5Y CAGR+121.4%
Year-over-Year Change
Net other income and expenses outside core operations
5Y CAGR
+121.4%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
53.2x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $11.01M | +105.0% |
| 2024 | $-221.63M | +57.9% |
| 2023 | $-526.14M | -7761.0% |
| 2022 | $-6.69M | -177.0% |
| 2021 | $-2.42M | -1267.5% |
| 2020 | $206943.00 | +102.0% |
| 2019 | $-10.16M | -375.1% |
| 2018 | $3.69M | +93.5% |
| 2017 | $1.91M | +278.9% |
| 2016 | $-1.07M | - |